TSB-9-W1 / Taiwan Sunpan Biotech 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
  • ||||||||||  TSB-9-W1 / Taiwan Sunpan Biotech
    Enrollment change, Trial initiation date, Trial suspension, Trial primary completion date, Metastases:  To Determine the MTD and to Evaluate the Safety, Efficacy and PK Profiles of TSB-9-W1 in Pre-treated Patients With mCRC. (clinicaltrials.gov) -  Jan 11, 2018   
    P1,  N=12, Suspended, 
    Suspended --> Completed | N=12 --> 21 | Trial completion date: Dec 2018 --> Aug 2020 | Trial primary completion date: Dec 2018 --> Feb 2020 N=30 --> 12 | Initiation date: May 2016 --> Jul 2017 | Not yet recruiting --> Suspended | Trial primary completion date: Nov 2017 --> Dec 2018
  • ||||||||||  TSB-9-W1 / Taiwan Sunpan Biotech
    Phase classification, Enrollment change, Trial initiation date, Metastases:  To Determine the MTD and to Evaluate the Safety, Efficacy and PK Profiles of TSB-9-W1 in Pre-treated Patients With mCRC. (clinicaltrials.gov) -  Apr 25, 2016   
    P1,  N=30, Not yet recruiting, 
    N=30 --> 12 | Initiation date: May 2016 --> Jul 2017 | Not yet recruiting --> Suspended | Trial primary completion date: Nov 2017 --> Dec 2018 Phase classification: P1/2 --> P1 | N=58 --> 30 | Initiation date: Jul 2015 --> May 2016